salsalate
Selected indexed studies
- Salsalate. (, 2012) [PMID:31644150]
- Salsalate. (, 2006) [PMID:30000946]
- Salsalate: a pleotropic anti-inflammatory drug in the treatment of diabetes, obesity, and metabolic diseases. (Inflammopharmacology, 2023) [PMID:37758933]
_Worker-drafted node — pending editorial review._
Connections
salsalate is a side effect of
Sources
- Salsalate. (2012) pubmed
- Salsalate. (2006) pubmed
- Salsalate: a pleotropic anti-inflammatory drug in the treatment of diabetes, obesity, and metabolic diseases. (2023) pubmed
- Salsalate reduces atherosclerosis through AMPKβ1 in mice. (2021) pubmed
- Salsalate negatively impacts microvascular function in women with endometriosis. (2025) pubmed
- Salsalate improves the anti-tumor efficacy of lenvatinib in MASH-driven hepatocellular carcinoma. (2025) pubmed
- Short salsalate administration affects cell proliferation, metabolism, and inflammation in polycystic kidney disease. (2023) pubmed
- Salsalate and/or metformin therapy confer beneficial metabolic effects in olanzapine treated female mice. (2023) pubmed
- Salsalate, an old, inexpensive drug with potential new indications: a review of the evidence from 3 recent studies. (2014) pubmed
- Salsalate Improves Postprandial Glycemic and Some Lipid Responses in Persons With Tetraplegia: A Randomized Clinical Pilot Trial With Crossover Design. (2023) pubmed